AU2001263160A1 - Utilization of non-viral sequences for minus-strand dna transfer and gene reconstitution - Google Patents

Utilization of non-viral sequences for minus-strand dna transfer and gene reconstitution

Info

Publication number
AU2001263160A1
AU2001263160A1 AU2001263160A AU6316001A AU2001263160A1 AU 2001263160 A1 AU2001263160 A1 AU 2001263160A1 AU 2001263160 A AU2001263160 A AU 2001263160A AU 6316001 A AU6316001 A AU 6316001A AU 2001263160 A1 AU2001263160 A1 AU 2001263160A1
Authority
AU
Australia
Prior art keywords
minus
utilization
strand dna
dna transfer
viral sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001263160A
Inventor
Wei-Shau Hu
Vinay K Pathak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU2001263160A1 publication Critical patent/AU2001263160A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13041—Use of virus, viral particle or viral elements as a vector
    • C12N2740/13043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/50—Vector systems having a special element relevant for transcription regulating RNA stability, not being an intron, e.g. poly A signal
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2840/00—Vectors comprising a special translation-regulating system
    • C12N2840/20—Vectors comprising a special translation-regulating system translation of more than one cistron
    • C12N2840/203—Vectors comprising a special translation-regulating system translation of more than one cistron having an IRES

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001263160A 2000-05-19 2001-05-15 Utilization of non-viral sequences for minus-strand dna transfer and gene reconstitution Abandoned AU2001263160A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20539500P 2000-05-19 2000-05-19
US60205395 2000-05-19
PCT/US2001/015739 WO2001090391A2 (en) 2000-05-19 2001-05-15 Utilization of non-viral sequences for minus-strand dna transfer and gene reconstitution

Publications (1)

Publication Number Publication Date
AU2001263160A1 true AU2001263160A1 (en) 2001-12-03

Family

ID=22762015

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001263160A Abandoned AU2001263160A1 (en) 2000-05-19 2001-05-15 Utilization of non-viral sequences for minus-strand dna transfer and gene reconstitution

Country Status (3)

Country Link
US (2) US7101541B2 (en)
AU (1) AU2001263160A1 (en)
WO (1) WO2001090391A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2832424B1 (en) * 2001-11-20 2004-09-24 Genethon Iii CHIMERIC PLASMID COMPRISING A REPLICATIVE RETROVIRAL GENOME AND USES
US20070042494A1 (en) * 2005-05-31 2007-02-22 Tal Kafri Heterologous retroviral packaging system

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4830965A (en) 1983-12-12 1989-05-16 Canadian Patents And Development Ltd. Transposable linkers to transfer genetic information
US5658775A (en) 1988-05-17 1997-08-19 Sloan-Kettering Institute For Cancer Research Double copy retroviral vector
WO1993010218A1 (en) 1991-11-14 1993-05-27 The United States Government As Represented By The Secretary Of The Department Of Health And Human Services Vectors including foreign genes and negative selective markers
US6013517A (en) 1994-05-09 2000-01-11 Chiron Corporation Crossless retroviral vectors
US5714353A (en) 1994-05-24 1998-02-03 Research Corporation Technologies, Inc. Safe vectors for gene therapy
DK0781343T3 (en) 1994-09-08 2003-10-27 Vision 7 Gmbh Retroviral vector hybrids and their use for gene transfer
FR2737731B1 (en) 1995-08-07 1997-10-10 Pasteur Institut SEQUENCE OF NATURAL OR SYNTHETIC BACKSETS HAVING THE FUNCTION OF ALLOWING THE INSERTION OF NUCLEOTIDE SEQUENCES IN A EUKARYOTE CELL
GB9621680D0 (en) 1996-10-17 1996-12-11 Oxford Biomedica Ltd Lentiviral vectors
AU2419599A (en) 1998-01-06 1999-07-26 Bavarian Nordic Research Institute A/S Reconstituting retroviral vector (recon vector) for targeted gene expression

Also Published As

Publication number Publication date
US20040048379A1 (en) 2004-03-11
US7101541B2 (en) 2006-09-05
US20060052325A1 (en) 2006-03-09
WO2001090391A2 (en) 2001-11-29
WO2001090391A3 (en) 2002-04-11

Similar Documents

Publication Publication Date Title
AU3199699A (en) Modified nucleotides and methods useful for nucleic acid sequencing
AU5579699A (en) Rapid amperometric verification of pcr amplification of dna
AU1606897A (en) Thymidine kinase variants, corresponding nucleic acid sequences and their use in gene therapy
AU3719700A (en) Enzymatic dna molecules that contain modified nucleotides
AU5584999A (en) System for the rapid manipulation of nucleic acid sequences
AU3304497A (en) Serpin enzyme complex receptor-mediated gene transfer
AU6097100A (en) Crosslinked dna condensate compositions and gene delivery methods
AU1410399A (en) Nucleic acid transfer vector for the introduction of nucleic acid into the dna of a cell
AU8242298A (en) Gene transfer method with the use of serum-free medium
AU2686200A (en) Novel nucleic acid and amino acid sequences
AU2001225487A1 (en) Use of paramyxovirus vector in gene transfer into blood vessel
EP1144682A3 (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
AU4174397A (en) Methods for identification and isolation of specific nucleotide sequences in cdna and genomic dna
AU2002234053A1 (en) Lentiviral vector-mediated gene transfer and uses thereof
EP1581614A3 (en) Nucleotide sequences for gene regulation and methods of use thereof
AU5328600A (en) Nucleotide sequences for gene regulation and methods of use thereof
AU6152000A (en) Copolymers for the transfer of nucleic acids to the cell
AU2001279561A1 (en) Method of selection in host cells with eliminated dna sequences
AU2001263160A1 (en) Utilization of non-viral sequences for minus-strand dna transfer and gene reconstitution
AU2001251544A1 (en) Method of inducing tumor cell apoptosis using trail/apo-2 ligand gene transfer
AU2001264845A1 (en) Nucleotide sequences encoding ramosa 1 gene and methods of use for same
AU7987800A (en) Anti-aging nucleic acid and protein targets
AU6488800A (en) Dna sequences specific to rice centromeres
EP1090997A4 (en) Hcv-derived rna polymerase gene
AU5545700A (en) Dna manipulation methods and applications for synthetic enzymes